He postulated that aggressive control of scalp inflammation, along with concurrent hair loss treatments, would increase one’s hair regrowth. DR RAFI then conducted several clinical trials in male and female patients using topical approaches to hair loss in men and women which also addressed scalp inflammation.
After 4 years of research in over 100 patients, he was able to develop his first highly effective topical product which promoted hair regrowth, optimal scalp health, and reduction of inflammation of the scalp. Now nearly 12 years later, Dr. Rafi has further refined his product to effectively treat women, non-allergic patients, patients with hair loss which is not pattern baldness, and younger adults. His initial research was published in a peer-reviewed manuscript in 2011.